Delivery of epirubicin via slow infusion as a strategy to mitigate chemotherapy-induced cardiotoxicity
Fang Yang(Shandong Maternal and Child Health Hospital), Runxiang Yang(Kunming Medical University), Jiajia Zeng(Kunming Medical University), Li Lü(Tongji Hospital), Sai‐Ching J. Yeung(The University of Texas MD Anderson Cancer Center), Jian He(Fudan University), Chunxiang Luo(Kunming Medical University)
Cited by 12
Related Papers
Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer
|JAMA Oncology|2019|694
Translocation of a calcium-permeable cation channel induced by insulin-like growth factor-I
|Nature Cell Biology|1999|491
A Whole‐Course‐Repair System Based on Neurogenesis‐Angiogenesis Crosstalk and Macrophage Reprogramming Promotes Diabetic Wound Healing
|Advanced Materials|2023|355